Michael S. Weiss

2015 - TG Therapeutics

In 2015, Michael S. Weiss earned a total compensation of $14M as Chief Executive Officer and President at TG Therapeutics.

Compensation breakdown

Non-Equity Incentive Plan$203,125
Salary$325,000
Stock Awards$13,440,772
Total$13,968,897

Weiss received $13.4M in stock awards, accounting for 96% of the total pay in 2015.

Weiss also received $203.1K in non-equity incentive plan and $325K in salary.

Rankings

In 2015, Michael S. Weiss' compensation ranked 272nd out of 13,638 executives tracked by ExecPay. In other words, Weiss earned more than 98.0% of executives.

ClassificationRankingPercentile
All
272
out of 13,638
98th
Division
Manufacturing
98
out of 5,190
98th
Major group
Chemicals And Allied Products
42
out of 1,854
98th
Industry group
Drugs
36
out of 1,528
98th
Industry
Pharmaceutical Preparations
29
out of 1,182
98th
Source: SEC filing on April 30, 2018.

Weiss' colleagues

We found one more compensation record of an executive who worked with Michael S. Weiss at TG Therapeutics in 2015.

2015

Sean Power

TG Therapeutics

Chief Financial Officer

News

You may also like